Skip to main content

Table 6 Relation between genotypes and socio-demographic data among HCC patients

From: Association between miR-196a2 polymorphism and the development of hepatocellular carcinoma in the Egyptian population

Studied variableGenotypeChi-square testP value
CC
N = 21
TC
N = 42
TT
N = 17
Age (years) X ± SD52.50 ± 4.62854.48 ± 4.7756.06 ± 6.3292.96*0.06
No.(%)No.(%)No.(%)  
Gender
 Male10(47.6)20(47.6)12(70.6)0.490.78
 Female11(52.4)22(52.4)5(29.4)
Smoking
 Yes12(57. 1)16(38. 1)10(58.8)3.150.20
 No9(42.9)26(61.9)7(41.2)
Family history
 Yes5(23.8)12(28.6)5(29.4)0.200.90
 No16(76.2)30(71.4)12(70.6)
Spleen
 Average5(23.8)5(11.9)1(5.9)2.50**0.25
 Splenomegaly16(76.2)37(88.1)16(94.1)
Liver
 Hepatomegaly6(28.6)7(16.7)5(29.4)3.010.55
 Cirrhotic14(66.7)34(81.0)12(70.6)
 Shrunken1(4.8)1(2.4)0(0.0)
Ascites
 Present16(76.2)38(90.5)13(76.5)3.200.20
 No5(23.8)4(9.5)4(23.5)
Encephalopathy
 Present12(57.1)28(66.7)10(58.8)0.660.71
 Absent9(42.9)14(33.3)7(41.2%)
Child score
 A7(33.3)13(31.0)4(23.5)1.61**0.80
 B6(28.6)17(40.5)6(35.3)
 C8(38.1)12(28.6)7(41.2)
  1. *ANOVA test
  2. **Fisher’s exact test